A Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects
- First Posted Date
- 2021-04-15
- Last Posted Date
- 2021-07-20
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 24
- Registration Number
- NCT04846998
- Locations
- 🇰🇷
Inha University Hospital, Incheon, Korea, Republic of
Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapY
- Conditions
- Metastatic Pancreatic CancerLocally Advanced Pancreatic Cancer
- First Posted Date
- 2021-03-10
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 1000
- Registration Number
- NCT04789980
- Locations
- 🇰🇷
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea, Republic of
Evaluate the Quality of Life and Treatment of Anxiety Symptoms of Buspirone in Patients With Depression Disorders(BASIS)
- Conditions
- Depressive Disorder, MajorAnxiety Disorders
- First Posted Date
- 2021-02-25
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 200
- Registration Number
- NCT04770454
- Locations
- 🇰🇷
the Catholic University of Korea, Yeouido St. Mary's Hospital, Seoul, Yeouido, Korea, Republic of
A Combination Drug Including Fimasartan and Statins in Patients With Hypertension and Dyslipidemia
- Conditions
- Hypertension and Dyslipidemia
- First Posted Date
- 2020-09-18
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 10877
- Registration Number
- NCT04554953
- Locations
- 🇰🇷
Chonnam National University Hospital, Gwangju, Jebong-ro, Jangseong-eup, Jangseong-gun, Korea, Republic of
Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor
- Conditions
- NSCLCHead and Neck CancerProstate CancerGastric CancerBreast CancerEsophageal CancerOvarian Cancer
- First Posted Date
- 2020-09-11
- Last Posted Date
- 2022-07-27
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 458
- Registration Number
- NCT04545632
- Locations
- 🇰🇷
Hanyang University Guri Hospital, Guri-si, Korea, Republic of
A Study to Evaluate Drug-drug Interactions Between BR9006-1 and BR9006-2 in Healthy Male Volunteers.
- Conditions
- Benign Prostatic Hyperplasia (BPH)Overactive Bladder
- Interventions
- Drug: BR9006-1Drug: BR9006-2
- First Posted Date
- 2020-07-24
- Last Posted Date
- 2020-10-28
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 36
- Registration Number
- NCT04485585
- Locations
- 🇰🇷
CHA Bundang Medical Center, CHA University, Seongnam-si, Gyeonggi-do, Korea, Republic of
A Study to Compare the Pharmacokinetics of BR4002 and BR4002-1 in Healthy Volunteers
- First Posted Date
- 2020-07-08
- Last Posted Date
- 2020-10-28
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 18
- Registration Number
- NCT04462029
- Locations
- 🇰🇷
Inha University Hospital, Incheon, Korea, Republic of
Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer
- Conditions
- Stage III Colon CancerStage II Colon Cancer
- First Posted Date
- 2020-06-04
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 2013
- Registration Number
- NCT04416490
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
VMP Regimen - Safety, Efficacy, and Optimal Dose Finding Study for Patients With Multiple Myeloma
- Conditions
- Multiple Myeloma
- First Posted Date
- 2019-11-05
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 203
- Registration Number
- NCT04151615
- Locations
- 🇰🇷
Inje university Haeundae Paik Hospital, Busan, Korea, Republic of
🇰🇷Yeungnam University Medical Center, Daegu, Korea, Republic of
🇰🇷Keimyung University Hospital(Dongsan Medical Center), Daegu, Korea, Republic of
NAC Inhalation in the Treatment Of Symptomatic acuTe rhinosinUSitis
- Conditions
- Chronic RhinosinusitisAcute RhinosinusitisRecurrent Acute Rhinosinusitis
- First Posted Date
- 2019-10-18
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 294
- Registration Number
- NCT04131686
- Locations
- 🇰🇷
The Catholic University of Korea, Yeouido ST. Mary's Hospital, Seoul, Korea, Republic of